115 related articles for article (PubMed ID: 38627012)
1. Improved Correlation of
Ikari Y; Akamatsu G; Matsumoto K; Yamane T; Senda M; Fukuchi K;
J Nucl Med Technol; 2024 Apr; ():. PubMed ID: 38627012
[TBL] [Abstract][Full Text] [Related]
2. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
3. Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [
Zhang H; Wang M; Lu J; Bao W; Li L; Jiang J; Zuo C;
Front Neurosci; 2021; 15():598234. PubMed ID: 34234637
[TBL] [Abstract][Full Text] [Related]
4. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity.
Southekal S; Devous MD; Kennedy I; Navitsky M; Lu M; Joshi AD; Pontecorvo MJ; Mintun MA
J Nucl Med; 2018 Jun; 59(6):944-951. PubMed ID: 29191858
[TBL] [Abstract][Full Text] [Related]
5. Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an
Wang M; Yan Z; Zhang H; Lu J; Li L; Yu J; Wang J; Matsuda H; Zuo C; Jiang J;
Quant Imaging Med Surg; 2021 Jan; 11(1):249-263. PubMed ID: 33392026
[TBL] [Abstract][Full Text] [Related]
6. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
7. Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression.
Kotari V; Southekal S; Navitsky M; Kennedy IA; Lu M; Morris A; Zimmer JA; Fleisher AS; Mintun MA; Devous MD; Pontecorvo MJ
Alzheimers Res Ther; 2023 Feb; 15(1):41. PubMed ID: 36855201
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography.
Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S
JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
Mundada NS; Rojas JC; Vandevrede L; Thijssen EH; Iaccarino L; Okoye OC; Shankar R; Soleimani-Meigooni DN; Lago AL; Miller BL; Teunissen CE; Heuer H; Rosen HJ; Dage JL; Jagust WJ; Rabinovici GD; Boxer AL; La Joie R
Alzheimers Res Ther; 2023 Sep; 15(1):157. PubMed ID: 37740209
[TBL] [Abstract][Full Text] [Related]
11. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
12. Regional [
Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
[TBL] [Abstract][Full Text] [Related]
13. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
14. Tau
Whittington A; Gunn RN;
J Nucl Med; 2021 Sep; 62(9):1292-1300. PubMed ID: 33517326
[TBL] [Abstract][Full Text] [Related]
15. Performance of a [
Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
Neurology; 2023 Nov; 101(19):e1850-e1862. PubMed ID: 37748892
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
17. Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study.
Cho H; Choi JY; Lee HS; Lee JH; Ryu YH; Lee MS; Jack CR; Lyoo CH
J Nucl Med; 2019 Nov; 60(11):1611-1621. PubMed ID: 30926651
[TBL] [Abstract][Full Text] [Related]
18. Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
Ossenkoppele R; Rabinovici GD; Smith R; Cho H; Schöll M; Strandberg O; Palmqvist S; Mattsson N; Janelidze S; Santillo A; Ohlsson T; Jögi J; Tsai R; La Joie R; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; Choi JY; Ryu YH; Lyoo CH; Hansson O
JAMA; 2018 Sep; 320(11):1151-1162. PubMed ID: 30326496
[TBL] [Abstract][Full Text] [Related]
19. One-Year Longitudinal Changes in Tau Accumulation on [
Oh M; Oh SJ; Lee SJ; Oh JS; Seo SY; Ryu S; Roh JH; Lee JH; Kim JS
J Nucl Med; 2024 Mar; 65(3):453-461. PubMed ID: 38302152
[TBL] [Abstract][Full Text] [Related]
20. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
